Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis (Q37074121)

18 August 2017

1 reference

title

Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis (English)

1 reference

18 August 2017

1 reference

Lev M Berstein

1

1 reference

PubMed ID

18240998

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

23-39

1 reference

18 August 2017

1

1 reference

Linkage of early-onset familial breast cancer to chromosome 17q21

18 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Hereditary breast cancer in Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1/2 carriers and endocrine risk modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Of mice and (wo)men: genotype-phenotype correlations in BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 in hormonal carcinogenesis: basic and clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Cellular functions of the BRCA tumour-suppressor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Cancer-susceptibility genes. Gatekeepers and caretakers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Insights into the functions of BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Growth retardation and tumour inhibition by BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Molecular functions of BRCA1 in the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Structural determinants of the BRCA1 : estrogen receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Origins of breast cancer subtypes and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

21 January 2018

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

The role of estrogen in the initiation of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Androgen pathway dysregulation in BRCA1-mutated breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Premature menopause in patients with BRCA1 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1-positive patients are small for gestational age compared with their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Low birthweight is associated with specific changes in muscle insulin-signalling protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Signs of proinflammatory/genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

The phenomenon of the switching of estrogen effects and joker function of glucose: similarities and relation to age-associated pathology and approaches to correction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Estrogen receptors in BRCA1-mutant breast cancer: now you see them, now you don't

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Risk of Endometrial Carcinoma Associated with BRCA Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.1.23

21 January 2018

Identifiers

DOI

10.2217/14796694.4.1.23

1 reference

18 August 2017

1 reference

PubMed ID

18240998